Learn more and explore every KidneyCure opportunity: https://bit.ly/kcgrantsfunding
Learn more and explore every KidneyCure opportunity: https://bit.ly/kcgrantsfunding
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
🔵 lifeact &
🔴 RFP-nls
Honored & grateful to receive an honorable mention at @healthcare.nikon.com Nikon Small World 🌍🔬✨
🔗 www.nikonsmallworld.com/galleries/20...
#NikonSmallWorld #Microscopy #ScienceArt
🔵 lifeact &
🔴 RFP-nls
Honored & grateful to receive an honorable mention at @healthcare.nikon.com Nikon Small World 🌍🔬✨
🔗 www.nikonsmallworld.com/galleries/20...
#NikonSmallWorld #Microscopy #ScienceArt
www.cell.com/cancer-cell/...
www.cell.com/cancer-cell/...
Let’s explore a powerful and underappreciated mechanism: Directed Cell Migration (DCM).
Preprint @biorxivpreprint.bsky.social : doi.org/10.1101/2025...
👇Thread 🧵(1/11)
Let’s explore a powerful and underappreciated mechanism: Directed Cell Migration (DCM).
Preprint @biorxivpreprint.bsky.social : doi.org/10.1101/2025...
👇Thread 🧵(1/11)
donmoynihan.substack.com/p/alert-the-...
donmoynihan.substack.com/p/alert-the-...
We are headed into an environment where pay lines are in the 5% range.
In my entire career, I’ve only had 3 grants that scored better than 5%. And my lab is considered a successful one.
This is going to destroy science.
We are headed into an environment where pay lines are in the 5% range.
In my entire career, I’ve only had 3 grants that scored better than 5%. And my lab is considered a successful one.
This is going to destroy science.
📹 Pierre-Emmanuel Y. N’Guetta et al @llobrienlab.bsky.social lab, University of North Carolina at Chapel Hill in
@cp-cellreports.bsky.social
➡️ bpod.org.uk/archive/2025... with John Ankers
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...